Compare VITL & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VITL | FTRE |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 944.3M | 1.5B |
| IPO Year | 2020 | 2023 |
| Metric | VITL | FTRE |
|---|---|---|
| Price | $20.14 | $10.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $42.56 | $15.39 |
| AVG Volume (30 Days) | ★ 2.1M | 2.0M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.03 | N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | $759,444,000.00 | ★ $2,723,400,000.00 |
| Revenue This Year | $26.07 | N/A |
| Revenue Next Year | $20.95 | $2.96 |
| P/E Ratio | $13.90 | ★ N/A |
| Revenue Growth | ★ 25.26 | 1.00 |
| 52 Week Low | $19.75 | $3.97 |
| 52 Week High | $53.13 | $18.67 |
| Indicator | VITL | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 23.04 | 32.76 |
| Support Level | N/A | $9.35 |
| Resistance Level | $29.73 | $11.41 |
| Average True Range (ATR) | 1.34 | 1.01 |
| MACD | -0.63 | 0.08 |
| Stochastic Oscillator | 2.93 | 57.60 |
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.